Eovist
Contrast Media Gadoxetate Disodium
181.43 mg / mL Intravenous Injection
Single Dose Vial 15 mL , 5/Box
MC 50419032015

Eovist
Contrast Media Gadoxetate Disodium
181.43 mg / mL Intravenous Injection
Single Dose Vial 15 mL , 5/Box
MC 50419032015

1- REGULATIONS ON PURCHASE OF THESE PRODUCTS VARY FROM STATE TO STATE . IT IS THE PURCHASER'S RESPONSIBILITY TO KNOW AND COMPLY WITH THE LAWS GOVERNING THE DISTRICT IN WHICH THEY LIVE. 2-THESE ITEMS WOULD BE USED ONLY BY QUALIFIED CUSTOMERS ( PHYSICIAN OFFICES , DIAGNOSTIC & RESEARCH LABORATORIES , HEALTH CARE PROVIDERS , .... ) WITH VALID PROFESSIONAL LICENSE. 3- ANY INQUIRY REGARDING THESE ITEMS WOULD BE PROCESSED AFTER VERIFICATION OF VALID LICENSE TO BE EMAILED AS AN ATTACHMENT TO : ADMIN@ALLMEDTECH.COM OR FAXED TO 323-782-0985 )

Manufacturer # 50419032015 Brand EovistŪ Manufacturer McKesson Specialty Application Contrast Media Container Type Single Dose Vial Dosage Form Injection Generic Drug Code 13287 Generic Drug Name Gadoxetate Disodium NDC Number 50419-0320-15 Strength 181.43 mg / mL Type Intravenous UNSPSC Code 51442200 Volume 15 mL Features

EovistŪ is a gadolinium-based MRI-contrast agent approved for intravenous use in magnetic resonance imaging (MRI) of the liver to detect and characterize lesions in patients with known or suspected focal liver disease EovistŪ injection is supplied in single-dose, rubber-stoppered vials containing 181.43 mg/mL of gadoxetate disodium, equivalent to 0.25 mmol/mL